Establishment by adriamycin exposure of multidrug-resistant rat ascites hepatoma AH130 cells showing low DT-diaphorase activity and high cross resistance to mitomycins
- PMID: 9045901
- PMCID: PMC5921242
- DOI: 10.1111/j.1349-7006.1997.tb00306.x
Establishment by adriamycin exposure of multidrug-resistant rat ascites hepatoma AH130 cells showing low DT-diaphorase activity and high cross resistance to mitomycins
Abstract
A resistant subline (AH130/5A) selected from rat hepatoma AH130 cells after exposure to adriamycin (ADM) showed remarkable resistance to multiple antitumor drugs, including mitomycin C (MMC) and porfiromycin (PFM). PFM, vinblastine (VLB), and ADM accumulated in AH130/5A far less than in the parent AH130 (AH130/P) cells. AH130/5A cells showed overexpression of P-glycoprotein (PGP), an increase in glutathione S-transferase activity, and a decrease in DT-diaphorase and glutathione peroxidase activity. The resistance to MMC and VLB of AH130/5A cells was partly reversed by H-87, an inhibitor of PGP. Buthionine sulfoximine, an inhibitor of glutathione synthase, did not affect the action of MMC. tert-Butylhydroquinone induced DT-diaphorase activity, increased PFM uptake, and enhanced the growth-inhibitory action of MMC in AH130/5A cells. Dicumarol, an inhibitor of DT-diaphorase, decreased PFM uptake and reduced the growth-inhibitory action of MMC in AH130/P cells. These results indicated that the adriamycin treatment of hepatoma cells caused multifactorial multidrug resistance involving a decrease in DT-diaphorase activity.
Similar articles
-
The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.J Surg Res. 1998 Dec;80(2):177-81. doi: 10.1006/jsre.1998.5481. J Surg Res. 1998. PMID: 9878310
-
The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.Cancer Chemother Pharmacol. 1992;31(1):23-31. doi: 10.1007/BF00695990. Cancer Chemother Pharmacol. 1992. PMID: 1458556
-
Induction of DT-diaphorase by doxorubicin and combination therapy with mitomycin C in vitro.Biochem Pharmacol. 1995 Oct 12;50(8):1281-6. doi: 10.1016/0006-2952(95)02014-4. Biochem Pharmacol. 1995. PMID: 7488245
-
[DT-diaphorase].Gan To Kagaku Ryoho. 1997 Sep;24(11):1606-10. Gan To Kagaku Ryoho. 1997. PMID: 9309161 Review. Japanese.
-
Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.Oncol Res. 1997;9(6-7):371-82. Oncol Res. 1997. PMID: 9406243 Review.
Cited by
-
Disposition kinetics of taxanes in peritoneal dissemination.Gastroenterol Res Pract. 2012;2012:963403. doi: 10.1155/2012/963403. Epub 2012 May 16. Gastroenterol Res Pract. 2012. PMID: 22666236 Free PMC article.
-
Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.Jpn J Cancer Res. 1998 Oct;89(10):1047-54. doi: 10.1111/j.1349-7006.1998.tb00495.x. Jpn J Cancer Res. 1998. PMID: 9849584 Free PMC article.
References
-
- ) Tsuruo , T. , Iida‐Saito , H. , Kawabata , H. , Ohhara , H. , Hamada , H. and Utakoji , T.Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to Adriamycin and in isolated clones . Jpn. J. Cancer Res. , 77 , 682 – 692 ( 1986. ). - PubMed
-
- ) Hagiwara , M. , Wakusawa , S. , ‐Miyamoto , K. and Hidaka , H.Obviation of drug resistance and affinity purification of P‐glycoprotein by isoquinolinesulfonamides . Cancer Lett. , 60 , 103 – 107 ( 1991. ). - PubMed
-
- ) Mizuno , K. , Furuhashi , Y. , Maeda , O. , Iwata , M. , Misawa , T. , Kawai , M. , Kano , T. and Tomoda , Y.Mitomycin C cross‐resistance induced by adriamycin in human ovarian cancer cells in vitro . Cancer Chemother. Pharmacol , 26 , 333 – 339 ( 1990. ). - PubMed
-
- ) Chen , Y. N. , Mickley , L. A. , Schwartz , A. M. , Acton , E. M. , Hwang , J. L. and Fojo , A. T.Characterization of adriamycin‐resistant human breast cancer cells which display overexpression of a novel resistance‐related membrane protein . J. Biol. Chem. , 265 , 10073 – 10080 ( 1990. ). - PubMed
-
- ) Scheper , R. J. , Broxtermann , H. J. , Scheffer , G. L. , Kaaijk , P. , Dalton , W. S. , van Heijinigen , T. H. M. , van Kalken , C. K. , Slovak , M. L. , de Vries , E. G. E. , van der Valk , P. , Meijer , C. J.L. M. and Pinedo , H. M.Overexpression of a Mr110,000 vesicular protein in non‐P‐glycoprotein‐mediated multidrug resistance . Cancer Res. 53 , 1475 – 1479 ( 1993. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous